Effects of Diet Interventions on Monocytes in Metabolic Syndrome
- Conditions
- Metabolic SyndromeHypertriglyceridemia
- Interventions
- Other: diet
- Registration Number
- NCT03591588
- Lead Sponsor
- Baylor College of Medicine
- Brief Summary
Subjects with hypertriglyceridemia and metabolic syndrome are being recruited and receive diet interventions with either a high-saturated fat diet or a low-fat high protein diet for 4 days (days 1-4) and a breakfast on day 5. Blood samples are collected on day 1 and day 5 to examine lipid levels and circulating monocyte phenotypes.
- Detailed Description
Subjects with hypertriglyceridemia and metabolic syndrome are being recruited and receive diet interventions with either a high-saturated fat diet or a low-fat high protein diet for 4 days (days 1-4) and a breakfast on day 5. Blood samples are collected on day 1 at fasting state and on day 5 at fasting state and 4 and 6 hours after the breakfast to examine lipid levels and circulating monocyte phenotypes.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- Obese women and men with metabolic syndrome (MS)
- Fasting triglyceride (TG) equal to or greater than 150 mg/dl
- <21 years of age
- Perimenopausal, pregnant or breastfeeding women
- Current smokers
- Obvious inflammation or other acute illnesses
- Obesity due to endocrinologic disorders including polycystic ovary syndrome
- Partial lipodystrophy
- Diabetes requiring insulin or >1 oral medication
- Fasting TG ≥650 mg/dl
- A history of pancreatitis
- Myocardial infarction within the past 3 years
- Any hospitalization within the past 2 months
- Takes steroids.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description low-fat diet diet Diet with low fat (\~25% calorie from fat) high-saturated fat diet diet Diet high in saturated fat (\~50% calorie from fat, \~25% from saturated fat)
- Primary Outcome Measures
Name Time Method Effects of diet interventions on monocyte phenotypes 2016 to 2020 Monocyte phenotypes
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Center for Prevention of cardiometabolic disease
🇺🇸Houston, Texas, United States